Hugen, C. and Morrison, G. and Gill, P. and El-Khoueiry, A. and Tsao-Wei, D. and Groshen, S. and Xu, Y. and Xu, T. and Kossari, N. and Kao, B. and Wei, J. and Rochefort, H. and Tai, Y. C. and Goldkorn, A. (2016) Circulating tumor cell analysis in a first-in-human phase I study of sEphB4-HSA, an inhibitor of EphrinB2-EphB4 signaling. European Journal of Cancer, 69 (S1). S126-S127. ISSN 0959-8049. doi:10.1016/S0959-8049(16)32976-8. https://resolver.caltech.edu/CaltechAUTHORS:20170112-102855601
Full text is not posted in this repository. Consult Related URLs below.
Use this Persistent URL to link to this item: https://resolver.caltech.edu/CaltechAUTHORS:20170112-102855601
Abstract
[no abstract]
Item Type: | Article | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Related URLs: |
| |||||||||
ORCID: |
| |||||||||
Additional Information: | © 2016 Elsevier Ltd. Available online 9 December 2016. | |||||||||
Issue or Number: | S1 | |||||||||
DOI: | 10.1016/S0959-8049(16)32976-8 | |||||||||
Record Number: | CaltechAUTHORS:20170112-102855601 | |||||||||
Persistent URL: | https://resolver.caltech.edu/CaltechAUTHORS:20170112-102855601 | |||||||||
Official Citation: | C. Hugen, G. Morrison, P. Gill, A. El-Khoueiry, D. Tsao-Wei, S. Groshen, Y. Xu, T. Xu, N. Kossari, B. Kao, J. Wei, H. Rochefort, Y.C. Tai, A. Goldkorn, 384 - Circulating tumor cell analysis in a first-in-human phase I study of sEphB4-HSA, an inhibitor of EphrinB2-EphB4 signaling, European Journal of Cancer, Volume 69, Supplement 1, December 2016, Pages S126-S127, ISSN 0959-8049, http://dx.doi.org/10.1016/S0959-8049(16)32976-8. (http://www.sciencedirect.com/science/article/pii/S0959804916329768) | |||||||||
Usage Policy: | No commercial reproduction, distribution, display or performance rights in this work are provided. | |||||||||
ID Code: | 73464 | |||||||||
Collection: | CaltechAUTHORS | |||||||||
Deposited By: | Tony Diaz | |||||||||
Deposited On: | 20 Jan 2017 00:39 | |||||||||
Last Modified: | 11 Nov 2021 05:16 |
Repository Staff Only: item control page